Current status of moleculartargeted drugs for endometrial cancer (Review)

Author： Nogami Yuya   Banno Kouji   Kisu Iori   Yanokura Megumi   Umene Kiyoko   Masuda Kenta   Kobayashi Yusuke   Yamagami Wataru   Nomura Hiroyuki   Tominaga Eiichiro   Susumu Nobuyuki   Aoki Daisuke  

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.1, Iss.5, 2013-09, pp. : 799-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Circulating Regulatory T Cells in Endometrial Cancer: A Role for Age and Menopausal Status

By Sawan Saladin   Burt Deborah J.   Stern Peter L.   Holland Cathrine   Elkord Eyad  

Immunological Investigations, Vol. 40, Iss. 1, 2011-01 ,pp. : 62-75

Informa Healthcare

Access to resources Recommend Favorite

What's happening? - Current status of high dose chemotherapy in breast cancer

By Gluck S.   Stewart D.  

Transfusion and Apheresis Science, Vol. 21, Iss. 3, 1999-12 ,pp. : 211-214

Elsevier

Access to resources Recommend Favorite

Angiopoietin-2 Axis Inhibitors: Current Status and Future Considerations for Cancer Therapy

By  

Current Angiogenesis, Vol. 2, Iss. 1, 2013-07 ,pp. : 2-12

Bentham Science Publishers

Access to resources Recommend Favorite

Multimodality Imaging of CXCR4 in Cancer: Current Status towards Clinical Translation

By  

Current Molecular Medicine, Vol. 13, Iss. 10, 2013-12 ,pp. : 1538-1548

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral Immunotherapy for Mosquito-Borne Flaviviruses: A Review of Current Status

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 10, Iss. 1, 2010-03 ,pp. : 31-42

Bentham Science Publishers

Access to resources Recommend Favorite